| scholarly article | Q13442814 |
| P2093 | author name string | Gerald G Wulf | |
| Lorenz Truemper | |||
| Ralf Jacob | |||
| Dirk Wenzel | |||
| Bjoern Chapuy | |||
| Thiha Aung | |||
| Raphael Koch | |||
| Sabrina Becker | |||
| Vivek Venkataramani | |||
| Daniel Vogel | |||
| Ursula Sinzig | |||
| Tobias von Mach | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | doxorubicin | Q18936 |
| P304 | page(s) | 395-404 | |
| P577 | publication date | 2015-09-14 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Nuclear Trapping through Inhibition of Exosomal Export by Indomethacin Increases Cytostatic Efficacy of Doxorubicin and Pixantrone | |
| P478 | volume | 22 |
| Q58785789 | Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer |
| Q60929868 | Cannabidiol Affects Extracellular Vesicle Release, miR21 and miR126, and Reduces Prohibitin Protein in Glioblastoma Multiforme Cells |
| Q90267081 | Cannabidiol Is a Novel Modulator of Bacterial Membrane Vesicles |
| Q47957249 | Chemoresistance in cancer cells: exosomes as potential regulators of therapeutic tumor heterogeneity |
| Q42229140 | Chloramidine/Bisindolylmaleimide-I-Mediated Inhibition of Exosome and Microvesicle Release and Enhanced Efficacy of Cancer Chemotherapy |
| Q102141394 | Exosomes and breast cancer drug resistance |
| Q33641799 | Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis |
| Q36390609 | Extracellular Vesicles in Hematological Malignancies: From Biology to Therapy |
| Q60939491 | Extracellular Vesicles: New Players in Lymphomas |
| Q89047141 | Extracellular vesicles direct migration by synthesizing and releasing chemotactic signals |
| Q57168926 | Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations |
| Q64100363 | Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance |
| Q28076203 | Impact of lysosome status on extracellular vesicle content and release |
| Q89456981 | Inhibiting extracellular vesicles formation and release: a review of EV inhibitors |
| Q39376074 | Intimate cross-talk between cancer cells and the tumor microenvironment of B-cell lymphomas: The key role of exosomes |
| Q46088676 | Mechanisms of Drug Resistance in Cancer: The Role of Extracellular Vesicles |
| Q64968938 | Mesenchymal stem cells confer chemoresistance in breast cancer via a CD9 dependent mechanism. |
| Q64252843 | Metastatic Niches and the Modulatory Contribution of Mesenchymal Stem Cells and Its Exosomes |
| Q89879539 | Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines |
| Q60927782 | Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme |
| Q39354673 | Peptidylarginine Deiminases-Roles in Cancer and Neurodegeneration and Possible Avenues for Therapeutic Intervention via Modulation of Exosome and Microvesicle (EMV) Release? |
| Q26748606 | The emerging roles of exosomes in leukemogeneis |
| Q26747281 | Transferring intercellular signals and traits between cancer cells: extracellular vesicles as "homing pigeons" |
Search more.